Literature DB >> 24397802

The frequencies of six important thrombophilic mutations in a population of the Czech Republic.

T Kvasnička1, J Hájková, P Bobčíková, V Cverhová, I Malíková, J Ulrych, J Bříza, D Dušková, S Poletínová, V Kieferová, J Kvasnička.   

Abstract

The primary aim was to determine frequencies of mutations related to risk of venous thrombosis in healthy Caucasians in Central Bohemia. In a cohort of 1527 healthy individuals the frequency of risk alleles for the mutations FV Leiden and FII 20210G>A was 4.5% and 1.3%, respectively. Frequency of 4G PAI-1 allele was 55.5%. Genotype frequencies were: GG 91.03%, GA 8.91%, and AA 0.07% for FV Leiden; GG 97.45%, GA 2.49%, and AA 0.07% for FII 20210G>A; 4G/4G 30.26%, 4G/5G 50.56%, and 5G/5G 19.19% for PAI-1. Frequency of the risk allele A in polymorphism SERPINC1 (IVS +141G >A) was 11.3%, and frequencies of genotypes were as follows: GG 78.36%, GA 20.66%, and AA 0.98%. Frequency of the risk allele T for polymorphism GP6 13254T>C was 87.7%, and frequencies of genotypes were as follows: TT 77.14%, TC 21.15%, and CC 1.70%. Frequency of the risk allele A in polymorphism CYP4V2 (Lys259Gln) was 65.2%, and frequencies of genotypes were: CC 12.25%, CA 45.12 %, and AA 42.63%. All observed genotypes and alleles frequencies were without gender differences. Their occurrences confirm a relatively high prevalence of hereditary thrombophilia predisposition in the Czech Republic.

Entities:  

Mesh:

Year:  2014        PMID: 24397802

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  3 in total

1.  Whole blood samples for faster real-time PCR analysis of thrombophilic mutations in SARS-CoV-2 virus positive patients.

Authors:  M Beránek; V Koblížek; P Dulíček; J Hegerová; V Palička
Journal:  Physiol Res       Date:  2022-05-26       Impact factor: 2.139

2.  A genetic risk factor for thrombophilia in a Han Chinese family.

Authors:  Guoping Sun; Yicong Jia; Jingye Meng; Minglin Ou; Peng Zhu; Shan Cong; Yadan Luo; Weiguo Sui; Yong Dai
Journal:  Mol Med Rep       Date:  2017-02-17       Impact factor: 2.952

3.  28 day post-operative persisted hypercoagulability after surgery for benign diseases: a prospective cohort study.

Authors:  Jan Ulrych; Tomas Kvasnicka; Vladimir Fryba; Martin Komarc; Ivana Malikova; Filip Burget; Radka Brzezkova; Jan Kvasnicka; Zdenek Krska; Jan Kvasnicka
Journal:  BMC Surg       Date:  2016-04-06       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.